Effect of the Method Pilates in Women With Temporomandibular Disorders
|ClinicalTrials.gov Identifier: NCT02292355|
Recruitment Status : Completed
First Posted : November 17, 2014
Last Update Posted : June 23, 2017
|Condition or disease||Intervention/treatment|
|Pain Temporomandibular Joint Disorders||Other: Pilates|
t-test or Mann-Whitney test will be used to compare data before and after 15 weeks of treatment.
Multiple Two-Way ANOVAs will be used to compare treatment and evaluation period, for each depended variable: effects of pain, severity of TMD, EMG activity of masticatory muscles and posture.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Effect of the Method Pilates in Women With Temporomandibular Disorders - Clinical Trial|
|Study Start Date :||March 2015|
|Primary Completion Date :||January 16, 2017|
|Study Completion Date :||June 2017|
Intervention group will undergo Pilates sessions in addition to conventional treatment with occlusal splint
The intervention group will perform Pilates exercises for 15 weeks with frequency of twice weekly
No Intervention: Occlusal splint
Control group who receive conventional treatment with occlusal splint
- Pain Intensity Measure [ Time Frame: 15 weeks ]Pain intensity will be assessed using visual analog scale (VAS), which consists of a 10-cm horizontal line in which "0" means "No pain" and "10" means "The worst pain I can imagine".
- Severity of TMD [ Time Frame: 15 weeks ]Severity of TMD will be assessed using the Mandibular Function Impairment Questionnaire (MFIQ).
- EMG activity of masticatory muscles [ Time Frame: 15 weeks ]EMG activity of masticatory muscles will be assessed using a surface eletromyography. Right and left masseter and temporalis muscles EMG activity will be record during 10 s of a masticatory activity
- Posture [ Time Frame: 15 weeks ]Women posture will be assessed with photogrametry
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02292355
|Universidade Federal do Rio Grande do Sul|
|Porto Alegre, RS, Brazil, 90690-200|
|Study Director:||Jefferson F Loss, Phd||Federal University of Rio Grande do Sul|